Cyclacel Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Cyclacel Pharmaceuticals, Inc.

Aug-04	CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB CYCC GlobeNewswire
Jul-16	CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY CYCC GlobeNewswire
Jul-07	CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER CYCC GlobeNewswire
Jul-07	CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT CYCC GlobeNewswire
Jun-03	CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT CYCC GlobeNewswire
May-15	CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE CYCC GlobeNewswire
May-07	CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT CYCC GlobeNewswire
May-06	CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE CYCC GlobeNewswire